Cite
MLA Citation
Ronan T. Swords et al.. “Pevonedistat (MLN4924), a First‐in‐Class NEDD8‐activating enzyme inhibitor, in patients with acute myeloid leukaemia and myelodysplastic syndromes: a phase 1 study.” British journal of haematology, vol. 169, n.d., pp. 534–543. http://access.bl.uk/ark:/81055/vdc_100050513012.0x000001